Equities Analysts Set Expectations for McKesson Q1 Earnings

McKesson Co. (NYSE:MCK - Free Report) - Analysts at Leerink Partnrs increased their Q1 2026 EPS estimates for shares of McKesson in a research report issued on Tuesday, May 27th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $8.74 for the quarter, up from their previous forecast of $8.73. The consensus estimate for McKesson's current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson's Q2 2026 earnings at $8.20 EPS and Q3 2026 earnings at $9.33 EPS.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $10.12 EPS for the quarter, topping the consensus estimate of $9.83 by $0.29. The company had revenue of $90.82 billion for the quarter, compared to the consensus estimate of $94 billion. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The firm's revenue was up 18.9% compared to the same quarter last year. During the same quarter last year, the firm posted $6.18 EPS.

Other research analysts also recently issued research reports about the stock. Cfra Research downgraded shares of McKesson from a "moderate buy" rating to a "hold" rating in a research note on Friday, April 4th. Wall Street Zen raised shares of McKesson from a "buy" rating to a "strong-buy" rating in a research report on Friday. UBS Group raised their target price on shares of McKesson from $708.00 to $805.00 and gave the company a "buy" rating in a research report on Tuesday, April 29th. Wells Fargo & Company raised their target price on shares of McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a research report on Friday, March 14th. Finally, Mizuho raised their target price on shares of McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research report on Thursday, April 3rd. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and a consensus price target of $686.69.

McKesson Stock Up 1.0%

MCK stock traded up $6.99 during trading on Thursday, hitting $719.85. The company had a trading volume of 1,322,227 shares, compared to its average volume of 917,774. The firm has a market capitalization of $90.06 billion, a P/E ratio of 32.96, a PEG ratio of 1.29 and a beta of 0.53. McKesson has a 52-week low of $464.42 and a 52-week high of $731.00. The company has a 50 day simple moving average of $695.18 and a 200-day simple moving average of $637.67.

Institutional Trading of McKesson

Institutional investors have recently bought and sold shares of the stock. CBIZ Investment Advisory Services LLC boosted its stake in McKesson by 1,366.7% in the 1st quarter. CBIZ Investment Advisory Services LLC now owns 44 shares of the company's stock worth $30,000 after purchasing an additional 41 shares in the last quarter. Capital A Wealth Management LLC acquired a new stake in McKesson in the 4th quarter worth approximately $26,000. Bank of Jackson Hole Trust boosted its stake in McKesson by 64.3% in the 1st quarter. Bank of Jackson Hole Trust now owns 46 shares of the company's stock worth $29,000 after purchasing an additional 18 shares in the last quarter. Millstone Evans Group LLC acquired a new stake in McKesson in the 4th quarter worth approximately $28,000. Finally, Saudi Central Bank acquired a new stake in McKesson in the 1st quarter worth approximately $34,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CFO Britt J. Vitalone sold 6,336 shares of the firm's stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $717.30, for a total value of $4,544,812.80. Following the sale, the chief financial officer now directly owns 14,760 shares in the company, valued at approximately $10,587,348. This trade represents a 30.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Thomas L. Rodgers sold 510 shares of McKesson stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $717.91, for a total transaction of $366,134.10. Following the completion of the sale, the executive vice president now owns 5,435 shares of the company's stock, valued at $3,901,840.85. This trade represents a 8.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,856 shares of company stock worth $7,793,675. Corporate insiders own 0.11% of the company's stock.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Stockholders of record on Monday, June 2nd will be issued a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date of this dividend is Monday, June 2nd. McKesson's dividend payout ratio is currently 10.99%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.